We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ATCC Licensing Program Aids Genmab Drug Development

News   Jan 09, 2006

 
ATCC Licensing Program Aids Genmab Drug Development
 
 
 

RELATED ARTICLES

Tuberculosis Tests are Inadequate, Better Options Identified

News

Rapid blood tests used by the NHS are unable to rule out tuberculosis (TB) and should be replaced with a new, more accurate test, a study has found.

READ MORE

Cellular Protein a Target for Zika Control

News

A cellular protein that interacts with invading viruses appears to help enable the infection process of the Zika virus, according to researchers who suggest this protein could be a key target in developing new therapies to prevent or treat Zika virus infection.

READ MORE

‘Shortcut’ Transforms Terpene Biosynthesis in E. Coli

News

Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE